Integrated analysis of competing endogenous RNA networks in peripheral blood mononuclear cells of systemic lupus erythematosus

Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some criti...

Full description

Saved in:
Bibliographic Details
Published inJournal of translational medicine Vol. 19; no. 1; pp. 1 - 15
Main Authors Song, Wencong, Qiu, Jie, Yin, Lianghong, Hong, Xiaoping, Dai, Weier, Tang, Donge, Liu, Dongzhou, Dai, Yong
Format Journal Article
LanguageEnglish
Published London BioMed Central 21.08.2021
BioMed Central Ltd
BMC
Subjects
Autoimmune diseases
Biomedical and Life Sciences
Biomedicine
ceRNAs
Development and progression
Disease
Genetic aspects
Genomes
Health aspects
Immunobiology and immunotherapy
Integrative analysis
Interferon
Interleukin 17
Kinases
Leukocytes (mononuclear)
Lupus
Lymphocytes
Medical diagnosis
Medicine/Public Health
MicroRNAs
miRNA
Monocytes
mRNA
Pathogenesis
Patients
Peripheral blood mononuclear cells
Physiological aspects
RNA
RNA sequencing
rRNA
Signal transduction
SLE
Stat1 protein
Stat2 protein
Systemic lupus erythematosus
TLR7 protein
Toll-like receptors
Tyk2 protein
China
United States > US
Integrative analysis
RNA sequencing
ceRNAs
SLE
Online AccessGet full text
ISSN1479-5876
1479-5876
DOI10.1186/s12967-021-03033-8

Cover

Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some critical signalling pathways and key competing endogenous RNAs (ceRNAs) underlying the molecular mechanism of SLE and to map out the systematic signalling networks by integrating the data on different kinds of RNAs. Methods Peripheral blood mononuclear cells (PBMCs) were collected from both SLE patients and healthy subjects, RNA was extracted from the PBMCs, and RNA libraries including ribosomal RNA-depleted strand-specific libraries and small RNA libraries were built for deep RNA sequencing (RNA-seq). RNA-seq yielded differential expression profiles of lncRNAs/circRNAs/miRNAs/mRNAs related to SLE. The DAVID database (v. 6.8) was employed for Gene Ontology (GO) and KEGG pathway analysis. ceRNA networks (circRNA/lncRNA-miRNA-mRNA) were constructed and visualized using Cytoscape software (v. 3.5.0). The TargetScan and miRanda databases were used to predict target relationships in ceRNA networks. qRT-PCR was used to verify our data. Results Differential expression of ceRNAs related to SLE was detected in SLE patients’ PBMCs: 644 mRNAs (384 upregulated, 260 downregulated), 326 miRNAs (223 upregulated, 103 downregulated), 221 lncRNAs (79 upregulated, 142 downregulated), and 31 circRNAs (21 upregulated, 10 downregulated). We drew ceRNA signalling networks made up of the differentially expressed mRNAs/miRNAs/lncRNAs/circRNAs mentioned above, and the hub genes included IRF5, IFNAR2, TLR7, IRAK4, STAT1, STAT2, C2, and Tyk2. These hub genes were involved in ceRNA signalling pathways, such as the IL-17 signalling pathway and type I interferon signalling pathway. Conclusions We explored the differential expression profiles of various kinds of ceRNAs and integrated signalling networks constructed by ceRNAs. Our findings offer new insights into the pathogenesis of SLE and hint at therapeutic strategies.
AbstractList Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some critical signalling pathways and key competing endogenous RNAs (ceRNAs) underlying the molecular mechanism of SLE and to map out the systematic signalling networks by integrating the data on different kinds of RNAs. Methods Peripheral blood mononuclear cells (PBMCs) were collected from both SLE patients and healthy subjects, RNA was extracted from the PBMCs, and RNA libraries including ribosomal RNA-depleted strand-specific libraries and small RNA libraries were built for deep RNA sequencing (RNA-seq). RNA-seq yielded differential expression profiles of lncRNAs/circRNAs/miRNAs/mRNAs related to SLE. The DAVID database (v. 6.8) was employed for Gene Ontology (GO) and KEGG pathway analysis. ceRNA networks (circRNA/lncRNA-miRNA-mRNA) were constructed and visualized using Cytoscape software (v. 3.5.0). The TargetScan and miRanda databases were used to predict target relationships in ceRNA networks. qRT-PCR was used to verify our data. Results Differential expression of ceRNAs related to SLE was detected in SLE patients’ PBMCs: 644 mRNAs (384 upregulated, 260 downregulated), 326 miRNAs (223 upregulated, 103 downregulated), 221 lncRNAs (79 upregulated, 142 downregulated), and 31 circRNAs (21 upregulated, 10 downregulated). We drew ceRNA signalling networks made up of the differentially expressed mRNAs/miRNAs/lncRNAs/circRNAs mentioned above, and the hub genes included IRF5, IFNAR2, TLR7, IRAK4, STAT1, STAT2, C2, and Tyk2. These hub genes were involved in ceRNA signalling pathways, such as the IL-17 signalling pathway and type I interferon signalling pathway. Conclusions We explored the differential expression profiles of various kinds of ceRNAs and integrated signalling networks constructed by ceRNAs. Our findings offer new insights into the pathogenesis of SLE and hint at therapeutic strategies.
Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some critical signalling pathways and key competing endogenous RNAs (ceRNAs) underlying the molecular mechanism of SLE and to map out the systematic signalling networks by integrating the data on different kinds of RNAs. Methods Peripheral blood mononuclear cells (PBMCs) were collected from both SLE patients and healthy subjects, RNA was extracted from the PBMCs, and RNA libraries including ribosomal RNA-depleted strand-specific libraries and small RNA libraries were built for deep RNA sequencing (RNA-seq). RNA-seq yielded differential expression profiles of lncRNAs/circRNAs/miRNAs/mRNAs related to SLE. The DAVID database (v. 6.8) was employed for Gene Ontology (GO) and KEGG pathway analysis. ceRNA networks (circRNA/lncRNA-miRNA-mRNA) were constructed and visualized using Cytoscape software (v. 3.5.0). The TargetScan and miRanda databases were used to predict target relationships in ceRNA networks. qRT-PCR was used to verify our data. Results Differential expression of ceRNAs related to SLE was detected in SLE patients’ PBMCs: 644 mRNAs (384 upregulated, 260 downregulated), 326 miRNAs (223 upregulated, 103 downregulated), 221 lncRNAs (79 upregulated, 142 downregulated), and 31 circRNAs (21 upregulated, 10 downregulated). We drew ceRNA signalling networks made up of the differentially expressed mRNAs/miRNAs/lncRNAs/circRNAs mentioned above, and the hub genes included IRF5, IFNAR2, TLR7, IRAK4, STAT1, STAT2, C2, and Tyk2. These hub genes were involved in ceRNA signalling pathways, such as the IL-17 signalling pathway and type I interferon signalling pathway. Conclusions We explored the differential expression profiles of various kinds of ceRNAs and integrated signalling networks constructed by ceRNAs. Our findings offer new insights into the pathogenesis of SLE and hint at therapeutic strategies.
Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some critical signalling pathways and key competing endogenous RNAs (ceRNAs) underlying the molecular mechanism of SLE and to map out the systematic signalling networks by integrating the data on different kinds of RNAs. Methods Peripheral blood mononuclear cells (PBMCs) were collected from both SLE patients and healthy subjects, RNA was extracted from the PBMCs, and RNA libraries including ribosomal RNA-depleted strand-specific libraries and small RNA libraries were built for deep RNA sequencing (RNA-seq). RNA-seq yielded differential expression profiles of lncRNAs/circRNAs/miRNAs/mRNAs related to SLE. The DAVID database (v. 6.8) was employed for Gene Ontology (GO) and KEGG pathway analysis. ceRNA networks (circRNA/lncRNA-miRNA-mRNA) were constructed and visualized using Cytoscape software (v. 3.5.0). The TargetScan and miRanda databases were used to predict target relationships in ceRNA networks. qRT-PCR was used to verify our data. Results Differential expression of ceRNAs related to SLE was detected in SLE patients’ PBMCs: 644 mRNAs (384 upregulated, 260 downregulated), 326 miRNAs (223 upregulated, 103 downregulated), 221 lncRNAs (79 upregulated, 142 downregulated), and 31 circRNAs (21 upregulated, 10 downregulated). We drew ceRNA signalling networks made up of the differentially expressed mRNAs/miRNAs/lncRNAs/circRNAs mentioned above, and the hub genes included IRF5, IFNAR2, TLR7, IRAK4, STAT1, STAT2, C2, and Tyk2. These hub genes were involved in ceRNA signalling pathways, such as the IL-17 signalling pathway and type I interferon signalling pathway. Conclusions We explored the differential expression profiles of various kinds of ceRNAs and integrated signalling networks constructed by ceRNAs. Our findings offer new insights into the pathogenesis of SLE and hint at therapeutic strategies.
Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some critical signalling pathways and key competing endogenous RNAs (ceRNAs) underlying the molecular mechanism of SLE and to map out the systematic signalling networks by integrating the data on different kinds of RNAs.BACKGROUNDSystemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some critical signalling pathways and key competing endogenous RNAs (ceRNAs) underlying the molecular mechanism of SLE and to map out the systematic signalling networks by integrating the data on different kinds of RNAs.Peripheral blood mononuclear cells (PBMCs) were collected from both SLE patients and healthy subjects, RNA was extracted from the PBMCs, and RNA libraries including ribosomal RNA-depleted strand-specific libraries and small RNA libraries were built for deep RNA sequencing (RNA-seq). RNA-seq yielded differential expression profiles of lncRNAs/circRNAs/miRNAs/mRNAs related to SLE. The DAVID database (v. 6.8) was employed for Gene Ontology (GO) and KEGG pathway analysis. ceRNA networks (circRNA/lncRNA-miRNA-mRNA) were constructed and visualized using Cytoscape software (v. 3.5.0). The TargetScan and miRanda databases were used to predict target relationships in ceRNA networks. qRT-PCR was used to verify our data.METHODSPeripheral blood mononuclear cells (PBMCs) were collected from both SLE patients and healthy subjects, RNA was extracted from the PBMCs, and RNA libraries including ribosomal RNA-depleted strand-specific libraries and small RNA libraries were built for deep RNA sequencing (RNA-seq). RNA-seq yielded differential expression profiles of lncRNAs/circRNAs/miRNAs/mRNAs related to SLE. The DAVID database (v. 6.8) was employed for Gene Ontology (GO) and KEGG pathway analysis. ceRNA networks (circRNA/lncRNA-miRNA-mRNA) were constructed and visualized using Cytoscape software (v. 3.5.0). The TargetScan and miRanda databases were used to predict target relationships in ceRNA networks. qRT-PCR was used to verify our data.Differential expression of ceRNAs related to SLE was detected in SLE patients' PBMCs: 644 mRNAs (384 upregulated, 260 downregulated), 326 miRNAs (223 upregulated, 103 downregulated), 221 lncRNAs (79 upregulated, 142 downregulated), and 31 circRNAs (21 upregulated, 10 downregulated). We drew ceRNA signalling networks made up of the differentially expressed mRNAs/miRNAs/lncRNAs/circRNAs mentioned above, and the hub genes included IRF5, IFNAR2, TLR7, IRAK4, STAT1, STAT2, C2, and Tyk2. These hub genes were involved in ceRNA signalling pathways, such as the IL-17 signalling pathway and type I interferon signalling pathway.RESULTSDifferential expression of ceRNAs related to SLE was detected in SLE patients' PBMCs: 644 mRNAs (384 upregulated, 260 downregulated), 326 miRNAs (223 upregulated, 103 downregulated), 221 lncRNAs (79 upregulated, 142 downregulated), and 31 circRNAs (21 upregulated, 10 downregulated). We drew ceRNA signalling networks made up of the differentially expressed mRNAs/miRNAs/lncRNAs/circRNAs mentioned above, and the hub genes included IRF5, IFNAR2, TLR7, IRAK4, STAT1, STAT2, C2, and Tyk2. These hub genes were involved in ceRNA signalling pathways, such as the IL-17 signalling pathway and type I interferon signalling pathway.We explored the differential expression profiles of various kinds of ceRNAs and integrated signalling networks constructed by ceRNAs. Our findings offer new insights into the pathogenesis of SLE and hint at therapeutic strategies.CONCLUSIONSWe explored the differential expression profiles of various kinds of ceRNAs and integrated signalling networks constructed by ceRNAs. Our findings offer new insights into the pathogenesis of SLE and hint at therapeutic strategies.
Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some critical signalling pathways and key competing endogenous RNAs (ceRNAs) underlying the molecular mechanism of SLE and to map out the systematic signalling networks by integrating the data on different kinds of RNAs. Peripheral blood mononuclear cells (PBMCs) were collected from both SLE patients and healthy subjects, RNA was extracted from the PBMCs, and RNA libraries including ribosomal RNA-depleted strand-specific libraries and small RNA libraries were built for deep RNA sequencing (RNA-seq). RNA-seq yielded differential expression profiles of lncRNAs/circRNAs/miRNAs/mRNAs related to SLE. The DAVID database (v. 6.8) was employed for Gene Ontology (GO) and KEGG pathway analysis. ceRNA networks (circRNA/lncRNA-miRNA-mRNA) were constructed and visualized using Cytoscape software (v. 3.5.0). The TargetScan and miRanda databases were used to predict target relationships in ceRNA networks. qRT-PCR was used to verify our data. Differential expression of ceRNAs related to SLE was detected in SLE patients' PBMCs: 644 mRNAs (384 upregulated, 260 downregulated), 326 miRNAs (223 upregulated, 103 downregulated), 221 lncRNAs (79 upregulated, 142 downregulated), and 31 circRNAs (21 upregulated, 10 downregulated). We drew ceRNA signalling networks made up of the differentially expressed mRNAs/miRNAs/lncRNAs/circRNAs mentioned above, and the hub genes included IRF5, IFNAR2, TLR7, IRAK4, STAT1, STAT2, C2, and Tyk2. These hub genes were involved in ceRNA signalling pathways, such as the IL-17 signalling pathway and type I interferon signalling pathway. We explored the differential expression profiles of various kinds of ceRNAs and integrated signalling networks constructed by ceRNAs. Our findings offer new insights into the pathogenesis of SLE and hint at therapeutic strategies.
Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of effective diagnosis and treatment methods makes it necessary to explore the molecular mechanism of SLE. We aimed to identify some critical signalling pathways and key competing endogenous RNAs (ceRNAs) underlying the molecular mechanism of SLE and to map out the systematic signalling networks by integrating the data on different kinds of RNAs. Methods Peripheral blood mononuclear cells (PBMCs) were collected from both SLE patients and healthy subjects, RNA was extracted from the PBMCs, and RNA libraries including ribosomal RNA-depleted strand-specific libraries and small RNA libraries were built for deep RNA sequencing (RNA-seq). RNA-seq yielded differential expression profiles of lncRNAs/circRNAs/miRNAs/mRNAs related to SLE. The DAVID database (v. 6.8) was employed for Gene Ontology (GO) and KEGG pathway analysis. ceRNA networks (circRNA/lncRNA-miRNA-mRNA) were constructed and visualized using Cytoscape software (v. 3.5.0). The TargetScan and miRanda databases were used to predict target relationships in ceRNA networks. qRT-PCR was used to verify our data. Results Differential expression of ceRNAs related to SLE was detected in SLE patients' PBMCs: 644 mRNAs (384 upregulated, 260 downregulated), 326 miRNAs (223 upregulated, 103 downregulated), 221 lncRNAs (79 upregulated, 142 downregulated), and 31 circRNAs (21 upregulated, 10 downregulated). We drew ceRNA signalling networks made up of the differentially expressed mRNAs/miRNAs/lncRNAs/circRNAs mentioned above, and the hub genes included IRF5, IFNAR2, TLR7, IRAK4, STAT1, STAT2, C2, and Tyk2. These hub genes were involved in ceRNA signalling pathways, such as the IL-17 signalling pathway and type I interferon signalling pathway. Conclusions We explored the differential expression profiles of various kinds of ceRNAs and integrated signalling networks constructed by ceRNAs. Our findings offer new insights into the pathogenesis of SLE and hint at therapeutic strategies. Keywords: ceRNAs, Integrative analysis, SLE, RNA sequencing
ArticleNumber 362
Audience Academic
Author Qiu, Jie
Hong, Xiaoping
Liu, Dongzhou
Tang, Donge
Dai, Weier
Song, Wencong
Yin, Lianghong
Dai, Yong
Author_xml – sequence: 1
  givenname: Wencong
  surname: Song
  fullname: Song, Wencong
  organization: Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College, Jinan University (Shenzhen Peoples Hospital), The First Affiliated Hospital, Jinan University
– sequence: 2
  givenname: Jie
  surname: Qiu
  fullname: Qiu, Jie
  organization: School of Computer Science and Engineering, Yulin Normal University
– sequence: 3
  givenname: Lianghong
  surname: Yin
  fullname: Yin, Lianghong
  organization: The First Affiliated Hospital, Jinan University
– sequence: 4
  givenname: Xiaoping
  surname: Hong
  fullname: Hong, Xiaoping
  organization: Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College, Jinan University (Shenzhen Peoples Hospital)
– sequence: 5
  givenname: Weier
  surname: Dai
  fullname: Dai, Weier
  organization: College of Natural Science, University of Texas at Austin
– sequence: 6
  givenname: Donge
  surname: Tang
  fullname: Tang, Donge
  email: donge66@126.com
  organization: Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College, Jinan University (Shenzhen Peoples Hospital), Guangxi Key Laboratory of Metabolic Disease Research, Central Laboratory of Guilin NO. 924 Hospital
– sequence: 7
  givenname: Dongzhou
  surname: Liu
  fullname: Liu, Dongzhou
  email: liu_dz2001@sina.com
  organization: Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College, Jinan University (Shenzhen Peoples Hospital)
– sequence: 8
  givenname: Yong
  orcidid: 0000-0002-6840-9158
  surname: Dai
  fullname: Dai, Yong
  email: daiyong22@aliyun.com
  organization: Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College, Jinan University (Shenzhen Peoples Hospital), Guangxi Key Laboratory of Metabolic Disease Research, Central Laboratory of Guilin NO. 924 Hospital
BookMark eNp9Ustu1DAUjVARbQd-gJUlNmxS_IrjbJCqisdIFUgI1pbj3GQ8JHawHdBs-HY8M0VlKlR54dc5x_dcn8vizHkHRfGS4CtCpHgTCW1EXWJKSswwY6V8UlwQXjdlJWtx9s_6vLiMcYsx5RVvnhXnjHPSECwuit9rl2AIOkGHtNPjLtqIfI-Mn2ZI1g0IXOcHcH6J6Muna-Qg_fLhe0TWoRmCnTcQ9Ija0fsOTT6XuJgRdEAGxvEgFXcxwWQNGpc5i0DYpQ1MOvm4xOfF016PEV7czavi2_t3X28-lrefP6xvrm9LU0meSsEEbShhtJUdp0zymtciuwND-q7pQBLeCiPahtAOaEdl3zCJTd3LBrTJm1WxPup2Xm_VHOykw055bdXhwIdB6ZBsrlzVhnDa9qSCHue3QAvBZIVBVE3PWl1lrbdHrXlpJ-gMuJQ7cCJ6euPsRg3-p5K5JsZJFnh9JxD8jwViUpON-3ZpB7nNilbZbyO4rDP01QPo1i8h_9MeVXPOcU3xPWrQ2YB1vc_vmr2ouhZ1RYmghGbU1X9QeXT738nR6m0-PyHII8EEH2OAXhmbdLJ-b8uOimC1z6E65lDlHKpDDrPRVUEfUP-251ESO5JiBrsBwr3ZR1h_AKsR8XM
CitedBy_id crossref_primary_10_1016_j_berh_2024_101936
crossref_primary_10_3389_fimmu_2023_1093208
crossref_primary_10_1186_s12872_024_04387_9
crossref_primary_10_3390_ijms24032259
crossref_primary_10_3390_ijms24087088
crossref_primary_10_1155_2024_4596974
crossref_primary_10_1080_07853890_2024_2309607
crossref_primary_10_3390_brainsci12060758
crossref_primary_10_7717_peerj_17213
crossref_primary_10_1155_2022_4446016
crossref_primary_10_3389_fgene_2022_951243
crossref_primary_10_1038_s41598_022_27310_8
crossref_primary_10_1166_mex_2022_2305
crossref_primary_10_3389_fimmu_2023_1131355
Cites_doi 10.1002/jcp.28634
10.1016/j.autrev.2011.11.017
10.1093/rheumatology/kex260
10.1186/s13075-019-1853-7
10.1056/NEJMra1100359
10.1016/j.jaut.2009.11.001
10.18632/oncotarget.23206
10.1371/journal.pcbi.1003455
10.1371/journal.pgen.1002341
10.1038/nmeth.1923
10.1016/j.biopha.2018.08.161
10.18632/oncotarget.15569
10.1186/1423-0127-21-23
10.1042/CS20180403
10.1016/j.molimm.2018.07.029
10.1038/s41419-019-1744-5
10.1007/s10067-019-04467-8
10.1038/nprot.2008.73
10.1186/s13075-015-0632-3
10.1093/rheumatology/38.12.1177
10.1111/1756-185X.12783
10.1080/08830185.2020.1736058
10.1016/j.cell.2007.12.024
10.3389/fphar.2014.00265
10.1007/s00296-013-2902-1
10.5507/bp.2016.004
10.1016/j.autrev.2010.08.016
10.1002/art.1780400928
10.12659/MSM.906507
10.1007/s11060-018-2757-0
10.1002/art.30183
10.3899/jrheum.091123
10.1038/nbt.3122
10.3390/biom9060206
10.1177/0961203314551083
10.1016/j.ejbt.2019.06.004
10.1186/s13075-017-1488-5
10.1186/s41544-019-0032-y
10.12659/MSM.912801
10.1038/s41467-017-02672-0
10.1146/annurev-pathol-020117-043952
10.18632/oncotarget.20490
10.1177/0961203308089990
10.1089/cmb.2017.0096
10.1016/j.biopha.2018.06.175
10.1111/imm.12940
10.1016/j.jaut.2018.11.001
10.1186/gb-2013-14-4-r36
ContentType Journal Article
Copyright The Author(s) 2021
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021. The Author(s).
Copyright_xml – notice: The Author(s) 2021
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12967-021-03033-8
DatabaseName Springer Nature Link
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
ProQuest Central Health & Medical Collection (via ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1479-5876
EndPage 15
ExternalDocumentID oai_doaj_org_article_7c142bf15ef0423ea663850e659f3ba5
PMC8380341
A675216212
10_1186_s12967_021_03033_8
GeographicLocations China
United States--US
GeographicLocations_xml – name: China
– name: United States--US
GrantInformation_xml – fundername: The Key Research and Development Program of Guangdong Province
  grantid: No. 2019B020229001
– fundername: Sanming Project of Medicine in Shenzhen
  grantid: SYJY201704, SYJY201705
  funderid: http://dx.doi.org/10.13039/501100012151
– fundername: Shenzhen Key Medical Discipline Construction Fund
  grantid: SZXK011
– fundername: Young Scientists Fund
  grantid: No32000641
  funderid: http://dx.doi.org/10.13039/501100010909
– fundername: Science and Technology Planning Project of Shenzhen Municipality
  grantid: JCYJ20200109144218597; JCYJ20190807145815129
  funderid: http://dx.doi.org/10.13039/501100013093
– fundername: ;
  grantid: No32000641
– fundername: ;
  grantid: No. 2019B020229001
– fundername: ;
  grantid: JCYJ20200109144218597; JCYJ20190807145815129
– fundername: ;
  grantid: SYJY201704, SYJY201705
– fundername: ;
  grantid: SZXK011
GroupedDBID ---
0R~
29L
2WC
53G
5VS
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
AAYXX
ALIPV
CITATION
PMFND
3V.
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c584t-636292132b8d423847476147ec1fd9de814b6c6b912de2d28f9380c7f89eacf93
IEDL.DBID M48
ISSN 1479-5876
IngestDate Wed Aug 27 01:31:40 EDT 2025
Thu Aug 21 18:12:04 EDT 2025
Fri Sep 05 07:06:49 EDT 2025
Fri Jul 25 05:22:09 EDT 2025
Tue Jun 17 21:03:12 EDT 2025
Tue Jun 10 20:36:11 EDT 2025
Tue Jul 01 02:59:34 EDT 2025
Thu Apr 24 23:05:26 EDT 2025
Sat Sep 06 07:28:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Integrative analysis
RNA sequencing
ceRNAs
SLE
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c584t-636292132b8d423847476147ec1fd9de814b6c6b912de2d28f9380c7f89eacf93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6840-9158
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12967-021-03033-8
PMID 34419106
PQID 2574440720
PQPubID 43076
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_7c142bf15ef0423ea663850e659f3ba5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8380341
proquest_miscellaneous_2563696487
proquest_journals_2574440720
gale_infotracmisc_A675216212
gale_infotracacademiconefile_A675216212
crossref_citationtrail_10_1186_s12967_021_03033_8
crossref_primary_10_1186_s12967_021_03033_8
springer_journals_10_1186_s12967_021_03033_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-08-21
PublicationDateYYYYMMDD 2021-08-21
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-21
  day: 21
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Journal of translational medicine
PublicationTitleAbbrev J Transl Med
PublicationYear 2021
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References C Zhang (3033_CR40) 2018; 24
A Kechin (3033_CR23) 2017; 24
GC Wu (3033_CR9) 2017; 8
S Liu (3033_CR22) 2019; 25
LJ Li (3033_CR39) 2018; 155
Y Liang (3033_CR50) 2017; 9
ZJ Wei (3033_CR15) 2017; 21
K Lerang (3033_CR33) 2014; 23
D Kim (3033_CR25) 2013; 14
R Yin (3033_CR41) 2019; 41
GC Tsokos (3033_CR6) 2011; 365
S-Y Chen (3033_CR44) 2019; 38
T Celhar (3033_CR48) 2014; 5
B Langmead (3033_CR24) 2012; 9
M Husakova (3033_CR42) 2016; 160
S Tian (3033_CR12) 2019; 18
M Salmon (3033_CR45) 1999; 38
C Gérard (3033_CR34) 2014; 10
H Ye (3033_CR11) 2019; 21
LJ Zhu (3033_CR47) 2010; 37
Y Wu (3033_CR35) 2015; 17
PP Smith (3033_CR5) 2011; 10
Z Zhou (3033_CR3) 2019; 10
H Yang (3033_CR36) 2017; 8
Y Li (3033_CR49) 2019; 234
TJ Fang (3033_CR17) 2016; 19
HD Brightbill (3033_CR46) 2018; 9
F Rees (3033_CR2) 2017; 56
GC Wu (3033_CR37) 2019; 9
Y Yuan (3033_CR21) 2018; 137
A Eulalio (3033_CR8) 2008; 132
3033_CR51
M-Y Zhang (3033_CR10) 2018; 107
DS Cunninghame Graham (3033_CR30) 2011; 7
A Fava (3033_CR4) 2019; 96
W Xin (3033_CR14) 2018; 20
G Manyam (3033_CR27) 2013; 29
M Pertea (3033_CR26) 2015; 33
M Hochberg (3033_CR20) 1997; 40
S Liu (3033_CR28) 2019; 1
C Zhang (3033_CR13) 2018; 132
O Qingqing (3033_CR16) 2018; 101
CN Zhao (3033_CR38) 2018; 106
W Song (3033_CR43) 2020; 39
L Munoz (3033_CR19) 2008; 17
D Shah (3033_CR18) 2014; 21
ML Santiago-Raber (3033_CR31) 2010; 34
YF Zou (3033_CR7) 2014; 34
TD Schmittgen (3033_CR29) 2008; 3
RP Singh (3033_CR1) 2012; 11
Y Tada (3033_CR32) 2011; 63
References_xml – volume: 234
  start-page: 20342
  issue: 11
  year: 2019
  ident: 3033_CR49
  publication-title: J Cell Physiol.
  doi: 10.1002/jcp.28634
– volume: 11
  start-page: 664
  issue: 9
  year: 2012
  ident: 3033_CR1
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2011.11.017
– volume: 56
  start-page: 1945
  issue: 11
  year: 2017
  ident: 3033_CR2
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kex260
– volume: 21
  start-page: 1
  issue: 1
  year: 2019
  ident: 3033_CR11
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-019-1853-7
– volume: 365
  start-page: 2110
  issue: 22
  year: 2011
  ident: 3033_CR6
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1100359
– volume: 34
  start-page: 339
  issue: 4
  year: 2010
  ident: 3033_CR31
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2009.11.001
– volume: 9
  start-page: 14862
  issue: 19
  year: 2017
  ident: 3033_CR50
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.23206
– volume: 10
  start-page: e1003455
  issue: 1
  year: 2014
  ident: 3033_CR34
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1003455
– volume: 7
  start-page: e1002341
  issue: 10
  year: 2011
  ident: 3033_CR30
  publication-title: PLoS Genetics.
  doi: 10.1371/journal.pgen.1002341
– volume: 9
  start-page: 357
  issue: 4
  year: 2012
  ident: 3033_CR24
  publication-title: Nat Methods
  doi: 10.1038/nmeth.1923
– volume: 107
  start-page: 1720
  year: 2018
  ident: 3033_CR10
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.08.161
– volume: 8
  start-page: 23650
  issue: 14
  year: 2017
  ident: 3033_CR9
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.15569
– volume: 21
  start-page: 1
  issue: 1
  year: 2014
  ident: 3033_CR18
  publication-title: J Biomed Sci
  doi: 10.1186/1423-0127-21-23
– volume: 132
  start-page: 2285
  issue: 21
  year: 2018
  ident: 3033_CR13
  publication-title: Clin Sci.
  doi: 10.1042/CS20180403
– volume: 101
  start-page: 531
  year: 2018
  ident: 3033_CR16
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2018.07.029
– volume: 10
  start-page: 503
  issue: 7
  year: 2019
  ident: 3033_CR3
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1744-5
– volume: 38
  start-page: 1361
  issue: 5
  year: 2019
  ident: 3033_CR44
  publication-title: Clinical Rheumatology
  doi: 10.1007/s10067-019-04467-8
– volume: 18
  start-page: 2813
  issue: 4
  year: 2019
  ident: 3033_CR12
  publication-title: Exp Ther Med
– volume: 3
  start-page: 1101
  issue: 6
  year: 2008
  ident: 3033_CR29
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2008.73
– volume: 17
  start-page: 1
  issue: 1
  year: 2015
  ident: 3033_CR35
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-015-0632-3
– volume: 38
  start-page: 1177
  issue: 12
  year: 1999
  ident: 3033_CR45
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/38.12.1177
– volume: 19
  start-page: 968
  issue: 10
  year: 2016
  ident: 3033_CR17
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185X.12783
– volume: 39
  start-page: 163
  issue: 4
  year: 2020
  ident: 3033_CR43
  publication-title: Int Rev Immunol
  doi: 10.1080/08830185.2020.1736058
– volume: 132
  start-page: 9
  issue: 1
  year: 2008
  ident: 3033_CR8
  publication-title: Cell
  doi: 10.1016/j.cell.2007.12.024
– volume: 5
  start-page: 265
  year: 2014
  ident: 3033_CR48
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2014.00265
– volume: 34
  start-page: 347
  issue: 3
  year: 2014
  ident: 3033_CR7
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-013-2902-1
– volume: 160
  start-page: 327
  issue: 3
  year: 2016
  ident: 3033_CR42
  publication-title: Biomed Papers Med Faculty Univ Palacky Olomouc Czechoslovakia
  doi: 10.5507/bp.2016.004
– volume: 10
  start-page: 43
  issue: 1
  year: 2011
  ident: 3033_CR5
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2010.08.016
– volume: 40
  start-page: 1725
  issue: 9
  year: 1997
  ident: 3033_CR20
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.1780400928
– volume: 24
  start-page: 1930
  year: 2018
  ident: 3033_CR40
  publication-title: Med Sci Monitor
  doi: 10.12659/MSM.906507
– volume: 137
  start-page: 493
  issue: 3
  year: 2018
  ident: 3033_CR21
  publication-title: J Neuro Oncol.
  doi: 10.1007/s11060-018-2757-0
– volume: 63
  start-page: 738
  issue: 3
  year: 2011
  ident: 3033_CR32
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.30183
– volume: 37
  start-page: 1658
  issue: 8
  year: 2010
  ident: 3033_CR47
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.091123
– volume: 33
  start-page: 290
  issue: 3
  year: 2015
  ident: 3033_CR26
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.3122
– volume: 9
  start-page: 206
  issue: 6
  year: 2019
  ident: 3033_CR37
  publication-title: Biomolecules.
  doi: 10.3390/biom9060206
– volume: 23
  start-page: 1546
  issue: 14
  year: 2014
  ident: 3033_CR33
  publication-title: Lupus
  doi: 10.1177/0961203314551083
– volume: 41
  start-page: 37
  year: 2019
  ident: 3033_CR41
  publication-title: Electronic J Biotechnol.
  doi: 10.1016/j.ejbt.2019.06.004
– volume: 20
  start-page: 1
  issue: 1
  year: 2018
  ident: 3033_CR14
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-017-1488-5
– volume: 1
  start-page: 1
  issue: 1
  year: 2019
  ident: 3033_CR28
  publication-title: ExRNA
  doi: 10.1186/s41544-019-0032-y
– volume: 25
  start-page: 1679
  year: 2019
  ident: 3033_CR22
  publication-title: Med Sci Monitor
  doi: 10.12659/MSM.912801
– volume: 9
  start-page: 1
  issue: 1
  year: 2018
  ident: 3033_CR46
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-02672-0
– ident: 3033_CR51
  doi: 10.1146/annurev-pathol-020117-043952
– volume: 8
  start-page: 77400
  issue: 44
  year: 2017
  ident: 3033_CR36
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.20490
– volume: 21
  start-page: 2177
  issue: 9
  year: 2017
  ident: 3033_CR15
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 29
  start-page: 2657
  issue: 20
  year: 2013
  ident: 3033_CR27
  publication-title: Bioinformatics (Oxford, England)
– volume: 17
  start-page: 371
  issue: 5
  year: 2008
  ident: 3033_CR19
  publication-title: Lupus.
  doi: 10.1177/0961203308089990
– volume: 24
  start-page: 1138
  issue: 11
  year: 2017
  ident: 3033_CR23
  publication-title: J Comput Biol
  doi: 10.1089/cmb.2017.0096
– volume: 106
  start-page: 584
  year: 2018
  ident: 3033_CR38
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.06.175
– volume: 155
  start-page: 137
  issue: 1
  year: 2018
  ident: 3033_CR39
  publication-title: Immunology.
  doi: 10.1111/imm.12940
– volume: 96
  start-page: 1
  year: 2019
  ident: 3033_CR4
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2018.11.001
– volume: 14
  start-page: 1
  issue: 4
  year: 2013
  ident: 3033_CR25
  publication-title: Genome Biol
  doi: 10.1186/gb-2013-14-4-r36
SSID ssj0024549
Score 2.3995287
Snippet Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The...
Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The...
Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly unveiled. The lack of...
Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a complicated pathogenesis, and its aetiology has not been clearly...
SourceID doaj
pubmedcentral
proquest
gale
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Autoimmune diseases
Biomedical and Life Sciences
Biomedicine
ceRNAs
Development and progression
Disease
Genetic aspects
Genomes
Health aspects
Immunobiology and immunotherapy
Integrative analysis
Interferon
Interleukin 17
Kinases
Leukocytes (mononuclear)
Lupus
Lymphocytes
Medical diagnosis
Medicine/Public Health
MicroRNAs
miRNA
Monocytes
mRNA
Pathogenesis
Patients
Peripheral blood mononuclear cells
Physiological aspects
RNA
RNA sequencing
rRNA
Signal transduction
SLE
Stat1 protein
Stat2 protein
Systemic lupus erythematosus
TLR7 protein
Toll-like receptors
Tyk2 protein
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHiouCFoQgYKMhMQBosaO49jHBVG1SO0BUak3K36JlVbZarN74MJvZ2wnC6ECLhyznjjOvGcz_gzwWlgVJDe8FCLYkvPaoUlZWWKsVoZ5o0QX9w5fXonza_7pprn55aiv2BOW4YEz405bSzkzgTY-xBYO32GIlE3lRaNCbbqEXlqpaiqmJpQ9LHumLTJSnA4Y1dAhxHYEVOq6LuUsDCW0_rs--W6f5G8fS1MMOnsID8bkkSzyoh_BPd8fweHl-Hn8GL5fTOAPjnQj2ghZB2JTcoxTEt-7dYZlJZ-vFqTPTeADWfYkQh4njIEVSd3sBBV03Ue4425D4v_7aaqM_Ly0ZLW7xUn85luGfV0Pu-ExXJ99_PLhvBwPWCgt5h3bUmD0UgzrUSMd8hYDFW8xXLfe0uCU85JyI6wwijLnmWMyqFpWtg1Sob_GiydwgCvxT4HQ2nHlpLWmCtwaJo3yTeNR4ipSswLoxG9tR_TxeAjGSqcqRAqdZaRRRjrJSMsC3u7vuc3YG3-lfh_FuKeMuNnpB9QmPWqT_pc2FfAmKoGO1o3Ls924SQFfMuJk6QXWV4wKjPcFnMwo0SrtfHhSIz16hUGje-Q8ItJVBbzaD8c7Y6db71H4SCPiEYtYRxbQztRv9mbzkX75NSGDSxQPpiUFvJsU9efD_8y5Z_-Dc8_hPkv2hY6XnsDBdrPzLzBf25qXyTR_AEviPMs
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central Health & Medical Collection (via ProQuest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9QwFA-6gngRP7HuKhEED1p2mqZpcpJRXFZh9yAuzC00XzowtON05uBl_3bfS9MZ6uIep3nNJH3fycsvhLwVVgXJDc-FCDbnvHSgUlbm4KuVYd4o0eDZ4YtLcX7Fvy2qRVpw61NZ5WgTo6F2ncU18lMQLc4RzWv2cf07x1ujcHc1XaFxl9yL0GUgz_XikHBxSH7GgzJSnPbg28AsYFECiHZZ5nLijCJm_03LfLNa8p8t0-iJzh6RhymEpPOB54_JHd8-Ifcv0ib5U3L9dYSAcLRJmCO0C9TGEBm6pL513QDOSr9fzmk7lIL3dNlSBD6OSAMrGmvaKcy7axH0uNlQXOWPXQ34z0tLV7s1dOI3fwbw167f9c_I1dmXH5_P83TNQm4h-tjmAnyYYpCVGukguAJ3xWtw2rW3RXDKeVlwI6wwqmDOM8dkUKWc2TpIBVYbfjwnRzAS_4LQonRcOWmtmQVuDZNG-arywHeF1Cwjxfi9tU0Y5HgVxkrHXEQKPfBIA4905JGWGXm_f2c9IHDcSv0J2binRPTs-KDb_NRJGXVtC85MKCofsCzINxB2yWrmRaVCaZoqI-9QCDTqOAzPNumoAkwS0bL0HLIsVgjw-hk5mVCCbtpp8yhGOtmGXh8kOSNv9s34Jta7tR6YDzQCL1qEbDIj9UT8JjObtrTLXxEfXAJ7IDjJyIdRUA9__v8v9_L2sR6TByxqDhjW4oQcbTc7_wrisa15HZXuL7vbNIs
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature Link
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkRAXxFMECjISEgeIWDuOYx-Xiqqt1B4QlXqz4pdYaZWtNruHXvjtjB1nSyhU6jHx2HEy73j8GeCDsCpIbngpRLAl55VDlbKyRF-tDPNGiTbuHT49E0fn_OSivsgwOXEvzJ_r91SKLz36I1TlWEiA4lhVpbwPD2paibQwKw6ucfUw0Rk3xfyz38TxJHz-m1b4ZmXkX8ujyescPoHHOVwk84G_T-Ge757Bw9O8IP4cfh2PcA-OtBlfhKwCsSkcxiGJ79xqAGIl38_mpBvKvnuy6EgEOU6oAkuS6tcJiuSqiwDH7ZrEP_ppqAHreWHJcnuJg_j11QD0uuq3_Qs4P_z24-CozEcqlBYjjU0p0F8phhmokQ4DKXRNvEEH3XhLg1POS8qNsMIoypxnjsmgKjmzTZAKLTRevIQ9nIl_BYRWjisnrTWzwK1h0ihf1x55rCI1K4CO31vbjDcej71Y6pR3SKEHHmnkkU480rKAT7s-lwPaxq3UXyMbd5QRKTvdQAHSWfF0YylnJtDah1gC5FsMsWQ986JWoTJtXcDHKAQ66jNOz7Z5WwK-ZETG0nPMqBgV6OEL2J9Qoh7aafMoRjrbgV6jQeQ8YtDNCni_a449Y21b55H5SCPioYqYORbQTMRv8mbTlm7xM2GBS2QPBiIFfB4F9frh__9yr-9G_gYesaRJaFTpPuxt1lv_FmOxjXmXlPA3NB4tcw
  priority: 102
  providerName: Springer Nature
Title Integrated analysis of competing endogenous RNA networks in peripheral blood mononuclear cells of systemic lupus erythematosus
URI https://link.springer.com/article/10.1186/s12967-021-03033-8
https://www.proquest.com/docview/2574440720
https://www.proquest.com/docview/2563696487
https://pubmed.ncbi.nlm.nih.gov/PMC8380341
https://doaj.org/article/7c142bf15ef0423ea663850e659f3ba5
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_uA8QX8ROr5xJB8EGrmzZNkweR3eWOU9hFFhcWX0KTpufC0p7bXfBe_NudpO0e9U7xpdBmmm0yM5mZzeQ3AK-4kYVgmoWcFyZkLM5RpYwI0VZLHVkteebODk9n_HzBPi-T5QF05Y7aCaxvDe1cPanFZv3u54-rj6jwH7zCC_6-RpuF6u6SDVBk4zgUh3CMlom7YGzKxDX2XuLdYcpSGSa4DHSHaG7to2eoPJ7_zVX7ZiblH9up3kqd3Yd7rXtJRo08PIADWz6EO9N2A_0R_PrUwUPkJGvxSEhVEOPdZ-yS2DKvGuBWMp-NSNmkiddkVRIHiuxRCNbE57sTFOGqdIDI2Ya4HQDfVYMNvTJkvbvETuzmqgGGrepd_RgWZ6dfJ-dhW4IhNOiZbEOO9k1GGLFqkaPjhaaMpWjQU2tokcvcCso0N1xLGuU2yiNRyFgMTVoIiSs63jyBI_wS-xQIjXMmc2GMHhbM6EhoaZPEokxIRx0FQLv5VqbFJ3dlMtbKxymCq4ZHCnmkPI-UCODN_p3LBp3jn9Rjx8Y9pUPW9g-qzYVqFVWlhrJIFzSxhUsZshm6ZCIZWp7IItZZEsBrJwTKSSR-nsnaYww4SIekpUYYgUWUo0cQwEmPEvXW9Js7MVKd2CtcQBlzmHXDAF7um92bLheutMh8pOGuCCNGmgGkPfHrjazfUq6-e-xwgexBxyWAt52gXv_432fu2X8P-jncjbwS4fpLT-Bou9nZF-i2bfUADtNlOoDj8ensyxzvJnwy8H-BDLyW4nU-_vYbN_hDLw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLemTgIuiE8RGGAkEAeI1jiOax8Q6mBTy9YKTZu0m4kdBypVSWlaoV34k_gbec9JWoWJ3XatHdfx-47f-z1CXgurcskND4XIbch5nIFIWRmCrVaGOaNEirXDk6kYnfMvF8nFDvnT1sJgWmWrE72izkqL38j3gbU4RzSv_sfFzxC7RuHtattCo2aLY3f5C0K26sP4M9D3DWNHh2efRmHTVSC0YGxXoQCVrRgEYUZm4EuAduYQyvOBs1GeqczJiBthhVERyxzLmMxVLPt2kEsFSipH8CVQ-bscK1p7ZPfgcPr1dIvuB-FWW5ojxX4F1hQUEaZBgDDFcSg75s93CbhqC67mZ_5zSett39E9crdxWumw5rL7ZMcVD8itSXMt_5D8HregExlNG5QTWubUeqcclqSuyMoaDpaeToe0qJPPKzorKEIte2yDOfVZ9BROuiwQZjldUrxX8EvViNMzS-frBSzilpc13GxZratH5PxGSPCY9GAn7gmhUZxxlUlrTT_n1jBplEsSB5ymcDYLSNSet7YN6jk235hrH_1IoWsaaaCR9jTSMiDvNs8sasyPa2cfIBk3MxGv2_9QLr_rRvz1wEacmTxKXI6JSC4FR08mfScSlccmTQLyFplAo1aB7dm0KY6Al0R8Lj2EuI5FAvyMgOx1ZoI2sN3hlo10o40qvZWdgLzaDOOTmGFXOCA-zBHY2hHi14AMOuzXebPuSDH74RHJJZAH3KGAvG8Zdfvn_z-5p9fv9SW5PTqbnOiT8fT4GbnDvBSBWo_2SG-1XLvn4A2uzItGBCn5dtNS_xf4VnHM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFLdgSBMXxKcIG2AkJA4QrXEcxz6WQbUBqxBi0m5W_AWVqqRq2sMu_O285yQdYYDEsfGzm-R9x-_9TMhLYVWQ3PBUiGBTznMHKmVlCr5aGeaNEhX2Dp_Nxck5_3BRXPzSxR-r3Yctya6nAVGa6s3RyoVOxaU4asFLgYJjeQEIaZ6n8ia5xdH14XatOL5C24P0Z2iV-eO8kTuKqP3XbfP1esnfNk2jL5rdJXf6IJJOO67fIzd8fZ_sn_Xb5A_Ij9MBBMLRqkcdoU2gNgbJsCT1tWs6eFb6ZT6ldVcM3tJFTRH6OGINLGmsaqcgqE2NsMfVmuJ3_rhUhwC9sHS5XcEifn3Zwb827bZ9SM5n778en6T9QQuphfhjkwrwYopBXmqkg_AKHBYvwW2X3mbBKedlxo2wwqiMOc8ck0HlcmLLIBXYbfjxiOzBnfjHhGa548pJa80kcGuYNMoXhQfOK6RmCcmG961tj0KOh2EsdcxGpNAdjzTwSEceaZmQ17s5qw6D45_Ub5GNO0rEz44XmvU33aujLm3GmQlZ4QMWBvkKAi9ZTLwoVMhNVSTkFQqBRi2H27NV36wAD4l4WXoKeRbLBPj9hByOKEE77Xh4ECPdW4dWg5nkHJHpJgl5sRvGmVjxVntgPtAIPGoR8smElCPxGz3ZeKRefI8I4RLYA-FJQt4Mgnr1539_c0_-j_w52f_8bqY_nc4_HpDbLCoVWN3skOxt1lv_FIK1jXkW9fEnboc4pw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integrated+analysis+of+competing+endogenous+RNA+networks+in+peripheral+blood+mononuclear+cells+of+systemic+lupus+erythematosus&rft.jtitle=Journal+of+translational+medicine&rft.au=Song%2C+Wencong&rft.au=Qiu%2C+Jie&rft.au=Yin%2C+Lianghong&rft.au=Hong%2C+Xiaoping&rft.date=2021-08-21&rft.pub=BioMed+Central+Ltd&rft.issn=1479-5876&rft.eissn=1479-5876&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12967-021-03033-8&rft.externalDocID=A675216212
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon